Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8478668rdf:typepubmed:Citationlld:pubmed
pubmed-article:8478668lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8478668lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:8478668lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:8478668lifeskim:mentionsumls-concept:C0003123lld:lifeskim
pubmed-article:8478668lifeskim:mentionsumls-concept:C0006625lld:lifeskim
pubmed-article:8478668lifeskim:mentionsumls-concept:C0065879lld:lifeskim
pubmed-article:8478668lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:8478668lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:8478668lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:8478668pubmed:issue4lld:pubmed
pubmed-article:8478668pubmed:dateCreated1993-5-24lld:pubmed
pubmed-article:8478668pubmed:abstractTextSeveral placebo-controlled randomized clinical trials have demonstrated that megestrol acetate can result in appetite stimulation and nonfluid weight gain in patients with cancer anorexia/cachexia. The present trial was designed to compare megestrol acetate doses ranging from 160 to 1,280 mg/d.lld:pubmed
pubmed-article:8478668pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8478668pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8478668pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8478668pubmed:languageenglld:pubmed
pubmed-article:8478668pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8478668pubmed:citationSubsetIMlld:pubmed
pubmed-article:8478668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8478668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8478668pubmed:statusMEDLINElld:pubmed
pubmed-article:8478668pubmed:monthAprlld:pubmed
pubmed-article:8478668pubmed:issn0732-183Xlld:pubmed
pubmed-article:8478668pubmed:authorpubmed-author:GoldbergR MRMlld:pubmed
pubmed-article:8478668pubmed:authorpubmed-author:MortonR FRFlld:pubmed
pubmed-article:8478668pubmed:authorpubmed-author:MichalakJ CJClld:pubmed
pubmed-article:8478668pubmed:authorpubmed-author:TschetterL...lld:pubmed
pubmed-article:8478668pubmed:authorpubmed-author:LoprinziC LCLlld:pubmed
pubmed-article:8478668pubmed:authorpubmed-author:SchaidD JDJlld:pubmed
pubmed-article:8478668pubmed:authorpubmed-author:MailliardJ...lld:pubmed
pubmed-article:8478668pubmed:authorpubmed-author:AthmannL MLMlld:pubmed
pubmed-article:8478668pubmed:authorpubmed-author:HatfieldA KAKlld:pubmed
pubmed-article:8478668pubmed:issnTypePrintlld:pubmed
pubmed-article:8478668pubmed:volume11lld:pubmed
pubmed-article:8478668pubmed:ownerNLMlld:pubmed
pubmed-article:8478668pubmed:authorsCompleteYlld:pubmed
pubmed-article:8478668pubmed:pagination762-7lld:pubmed
pubmed-article:8478668pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:meshHeadingpubmed-meshheading:8478668-...lld:pubmed
pubmed-article:8478668pubmed:year1993lld:pubmed
pubmed-article:8478668pubmed:articleTitlePhase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.lld:pubmed
pubmed-article:8478668pubmed:affiliationDivision of Medical Oncology, Mayo Clinic, Rochester, MN 55905.lld:pubmed
pubmed-article:8478668pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8478668pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8478668pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8478668pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8478668pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:8478668pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8478668lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8478668lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8478668lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8478668lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8478668lld:pubmed